Before you sell to, join or invest in Flavocure Biotech, Inc.
MentionFox check on Flavocure Biotech, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/flavocure-biotech-inc-form-d-25000001
Check Flavocure Biotech, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Flavocure Biotech, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Flavocure Biotech, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-21.
Flavocure Biotech, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 21, 2025. The filing reports $215K sold. Its industry group is Biotechnology. It names Ngeh Toyang (Executive Officer, Director), Henry Lowe (Executive Officer, Director), Justin Grant (Director) (SEC Form D, February 21, 2025).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Flavocure Biotech, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-02-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Flavocure Biotech, Inc.
Free to see. No signup.
Get an email when Flavocure Biotech, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Flavocure Biotech, Inc. raises, hires or launches. No email unless you switch it on.
Watch Flavocure Biotech, Inc. →Get the full cited report on Flavocure Biotech, Inc.
What the filing shows about Flavocure Biotech, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Flavocure Biotech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Flavocure Biotech, Inc.'s address as 701 E Pratt St, Ste 2033, Baltimore, MD 21202.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Flavocure Biotech, Inc. See pricing
Flavocure Biotech, Inc. is a registered filer with the SEC (CIK 1960342) and has filed since 2023-01-04. 2 filings are on record, the latest on 2025-02-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Flavocure Biotech, Inc.'s Form D of 2025-02-21 names Ngeh Toyang, Henry Lowe, Justin Grant and 1 more as its officers, directors or promoters.
Its new offerings report $1.34M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 765 filings in Biotechnology, totalled by week.
Ngeh Toyang is named as Executive Officer and Director on the Form D that Flavocure Biotech, Inc. filed with the SEC on 21 February 2025, one of 4 people that filing names.
Henry Lowe is named as Executive Officer and Director on the Form D that Flavocure Biotech, Inc. filed with the SEC on 21 February 2025, one of 4 people that filing names.
Justin Grant is named as Director on the Form D that Flavocure Biotech, Inc. filed with the SEC on 21 February 2025, one of 4 people that filing names.
Douglas Liu is named as Executive Officer on the Form D that Flavocure Biotech, Inc. filed with the SEC on 21 February 2025, one of 4 people that filing names.
4 people named on the filing — 3 holding an executive role and 1 as a director only.
Named as of the 2025-02-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Flavocure Biotech, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Flavocure Biotech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Flavocure Biotech, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Flavocure Biotech, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Flavocure Biotech, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Flavocure Biotech, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Baltimore
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/flavocure-biotech-inc-form-d-25000001